Delivery Order SPE2DB22D2214-SPE2DB24FS5HL

Award Date 6/11/24
Potential Completion Date 6/12/24
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication. The $16,476.49 firm fixed-price delivery order has a completion date of July 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,782.20 firm fixed-price delivery order is for the supply of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product, with an ultimate completion date of November 7, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,246.55 Firm Fixed Price Delivery Order contract is for the provision of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,130.03 Firm Fixed Price Delivery Order contract is for the supply of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to AmerisourceBergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,431.67 firm fixed-price delivery order is for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication, with a completion date of May 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $18,792.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the supply of GILENYA 0.5 MG CAPSULE 30S, a prescription medication, to support military...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $14,874.16 with a firm fixed price pricing type and an ultimate completion date of April 9, 2025. The contract provides for the delivery of GILENYA 0.5 MG CAPSULE 30S, a specialty pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GILENYA 0.5 MG CAPSULE 30S, a specialty medication, with a ceiling value of $26,463.60. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 27, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $77,864.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $20,258.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GILENYA 0.5 MG CAPSULE 30S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 2, 2024. Amerisourcebergen has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal agencies, such as the Department of Justice Federal Bureau of...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB24FS5HL
    Delivery Order

This federal contract award, valued at $7,545.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D2214|SPE2DB24FS5HL) with a firm fixed price, covering the supply of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of June 12, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award was not designated with a set-aside requirement, indicating open competition.

Generated 5/17/25, 10:12 AM